Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2019, ended Dec 31, 2019 | — |
| FY2020, ended Dec 31, 2020 | — |
| FY2021, ended Dec 31, 2021 | $15.4B |
| FY2022, ended Dec 31, 2022 | $7.29B |
| FY2023, ended Dec 31, 2023 | $11.1B |
| FY2024, ended Dec 31, 2024 | $33.0B |
| FY2025, ended Dec 31, 2025 | $102B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $101B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2019, ended Dec 31, 2019 | $278M |
| FY2020, ended Dec 31, 2020 | $958M |
| FY2021, ended Dec 31, 2021 | $1.81B |
| FY2022, ended Dec 31, 2022 | $1.36B |
| FY2023, ended Dec 31, 2023 | $1.86B |
| FY2024, ended Dec 31, 2024 | $2.95B |
| FY2025, ended Dec 31, 2025 | $4.47B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $5.08B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2019, ended Dec 31, 2019 | −$107M | $1.25B |
| FY2020, ended Dec 31, 2020 | $7.00M | $1.85B |
| FY2021, ended Dec 31, 2021 | −$3.69B | −$948M |
| FY2022, ended Dec 31, 2022 | −$1.03B | −$880M |
| FY2023, ended Dec 31, 2023 | −$541M | $1.18B |
| FY2024, ended Dec 31, 2024 | $1.41B | −$170M |
| FY2025, ended Dec 31, 2025 | $1.88B | $1.62B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $1.98B | $3.01B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2019, ended Dec 31, 2019 | $644M |
| FY2020, ended Dec 31, 2020 | $1.40B |
| FY2021, ended Dec 31, 2021 | $6.25B |
| FY2022, ended Dec 31, 2022 | $6.34B |
| FY2023, ended Dec 31, 2023 | $4.83B |
| FY2024, ended Dec 31, 2024 | $4.33B |
| FY2025, ended Dec 31, 2025 | $4.26B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $5.83B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2019, ended Dec 31, 2019 | — |
| FY2020, ended Dec 31, 2020 | $0 |
| FY2021, ended Dec 31, 2021 | — |
| FY2022, ended Dec 31, 2022 | — |
| FY2023, ended Dec 31, 2023 | — |
| FY2024, ended Dec 31, 2024 | — |
| FY2025, ended Dec 31, 2025 | $0 |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $2.66B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 306% since FY19.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2019, ended Dec 31, 2019 | 222M |
| FY2020, ended Dec 31, 2020 | 229M |
| FY2021, ended Dec 31, 2021 | 868M |
| FY2022, ended Dec 31, 2022 | 896M |
| FY2023, ended Dec 31, 2023 | 875M |
| FY2024, ended Dec 31, 2024 | 885M |
| FY2025, ended Dec 31, 2025 | 900M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 900M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2019, ended Dec 31, 2019 | — | $26.7M |
| FY2020, ended Dec 31, 2020 | — | $24.0M |
| FY2021, ended Dec 31, 2021 | $0 | $1.57B |
| FY2022, ended Dec 31, 2022 | $0 | $654M |
| FY2023, ended Dec 31, 2023 | $608M | $871M |
| FY2024, ended Dec 31, 2024 | $257M | $304M |
| FY2025, ended Dec 31, 2025 | $653M | $305M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $789M | $353M |
Valuation
At current price- Market Cap
- $85.2B
- P/E
- 42.9×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 16.8×
- Price / Book
- 8.4×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $5.08B
- Revenue Growth YoY
- 20.9%
- Revenue CAGR 3Y
- 48.8%
- Revenue CAGR 5Y
- 36.1%
- EPS Growth YoY
- −9.6%
- Net Income Growth YoY
- −9.6%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- —
- Net Margin
- 39.0%
- FCF Margin
- 59.3%
- Return on Equity
- 21.3%
Earnings
Trailing 12 months- Net Income
- $1.98B
- EPS (diluted)
- $2.17
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- —
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $5.83B
- Total Debt
- $2.66B
- Net Cash
- $3.17B
- Total Assets
- $58.3B
- Total Liabilities
- $48.2B
- Shareholders' Equity
- $10.1B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $3.05B
- Capital Expenditure
- $33.0M
- Free Cash Flow
- $3.01B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 2.34
Every ratio is calculated from the company’s reported figures.